Medigene to Host Virtual R&D Event on their Optimal 3S TCRs for TCR-Guided Precision Immunotherapies
Medigene AG, an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, will host an R&D Event on their optimal 3S (specific, sensitive, and safe) TCRs for TCR-guided precision immunotherapies on Thursday, October 10, 2024, at 4.30 pm CET / 10:30 am ET. A live Q&A session will follow the formal presentations and discussions.
Management will discuss the advantages of the Company’s 3S TCRs across a wide range of modalities, including TCR-engineered T cell (TCR-T) therapies, TCR-guided T cell engager therapies (TCR-TCE), and TCR-natural killer cell therapies (TCR-NK).
Additionally, Principal Investigator of the EPITOME1015-I trial, Dr. David B. Zhen, Associate Professor at both the Fred Hutchinson Cancer Center and the University of Washington School of Medicine, will provide a comprehensive overview of the Company’s lead program, MDG1015. His presentation will highlight the innovative approach taken with Medigene’s lead third generation TCR-T therapy program, MDG1015, which targets the unmet needs that remain for treating solid tumors, despite recently approved first generation TCR-T therapies.
Finally, the presentation will cover Medigene’s proprietary End-to-End Platform, where multiple technologies can be deployed in a modular approach to generate multiple TCR-guided modalities, both cellular and antibody based, along with the latest advancements.
Attendees are invited to listen to the presentations and discussions as well as participate in the Q&A session.
Full details for the webcast and registration are as follows:
Date: October 10, 2024
Time: 4.30 pm CET / 10:30 am ET
Location: Virtual
Webcast registration here.
Following the call, an archived webcast will also be accessible on the Medigene website.
Other posts featuring Medigene AG.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023